Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Pharma Industry News Dr. Reddy’s launches Sapropterin Dihydrochloride Tablets generic version in US Indian pharma company Dr. Reddy’s Laboratories has launched a generic version of phenylalanine hydroxylase activator Sapropterin Dihydrochloride Tablets,… bypharmanewsdailyOctober 4, 2020
